| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.8B | $13.7B | $13.7B | $12.9B | $12.4B | $3.7B | $4.0B | $3.8B |
| Cost of Revenue | — | — | — | — | — | $10.1B | $11.6B | $11.6B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B | $0.5B | $0.6B | $0.6B |
| SG&A Expense | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | $1.0B | $1.2B | $1.3B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.9B | $0.8B | $0.9B | $0.9B | $0.7B | $0.3B | $0.8B | $0.2B |
| EPS (Basic) | $5.15 | $4.38 | $4.61 | — | — | — | — | $1.02 |
| EPS (Diluted) | $5.11 | $4.33 | $4.56 | — | — | — | — | $1.02 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.1B | $16.8B | $16.9B | $16.3B | $15.8B | $15.4B | $15.0B | $14.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $10.3B | $9.6B | $9.9B | $9.2B | $9.0B | $9.6B | $9.5B | $9.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.9B | $7.2B | $7.0B | $7.1B | $6.8B | $5.8B | $5.5B | $5.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.0B | $1.3B | $1.5B | $1.6B | $0.8B | $1.0B | $1.1B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.3B | $-0.4B | $-0.3B | $-0.2B | $-0.3B | $0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-1.5B | $-0.8B | $-1.1B | $-1.4B | $0.4B | $-0.5B | $-1.9B |